Caligenix

Caligenix Overview

Caligenix is a biotechnology company developing personalized genomic diagnostic kits. The companys mission is to increase understanding of the link between genetic variation and individual dietary response as well as the overall role of nutrients in gene expression. The company is set to enable its B2B clients to further customize and optimize their health and wellness offerings based on genomic data. Through research and technological development, Caligenix undertakes different activities in order to develop and improve new products and services. Caligenix currently offers two tests. Both tests consist of a panel of 45 genetic markers related to several important aspects of the customers lifestyle, including weight management and body composition, nutrient metabolism, eating habits, cardiometabolic health, food intolerances, and physical activity. The Caligenix Health and Wellness test is intended for the general public to optimize health and well-being, and the Sports test is focused on enhancing performance and decreasing injury risk while optimizing health. The simple saliva tests are processed in CLIA-certified and CAP-accredited labs and included in a personalized report. All reports are available online on both desktop and mobile.

Cumulative Funding Raised Over Time ($)

Latest News

May 3, 2021 · www.prweb.com

growth-positive

Genetic Wellness Company, Caligenix to Launch Personalized Skincare and Nutrition Brands Leveraging Real-Time RNA

Caligenix announces the launch of two genomic-based wellness brands, Dermatype and Biotype, offering personalized skincare and nutrition products based on individual genomic DNA. The products utilize advanced technologies, AI algorithms, and genomics to provide consumers with insight into their unique needs and empower them to make positive changes. Dermatype offers an end-to-end skincare system with personalized serums based on stem cell technology, while Biotype focuses on personalized nutrition. Caligenix aims to personalize nutrition and skincare, allowing consumers to monitor the effects on their health. The company previously introduced Immunotype, a DNA-based supplement, and an Environmental Health Impact Index tool. The Dermatype and Biotype products are currently in trials.

CustomersPartners

Dec 3, 2020 · www.prweb.com

growth-positive

Caligenix Enters Nutritional Supplement Space with Product Launch of Immunotype

Caligenix has launched Immunotype, a DNA-based supplement that addresses the human immune system at the level of the genome. The company aims to personalize nutrition and skincare using genomic technologies and actionable products. They have appointed Dr. Steve Henig as Chief Science Officer to lead the scientific team. Caligenix has been selected by leading multi-national CPG corporations for personalized nutrition pilots. The companys mission is to provide next-generation wellness supplements and skincare solutions based on individual genetic data.

CustomersInvestmentManagement Changes

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Aluf Kalman Magen St 3, Tel Aviv-Yafo, Israel

10250 Constellation Blvd, Century City, Los Angeles, California 90067, USA

Photos & Videos

4 item(s)

Caligenix Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info